Health
Alzheimer’s Drug Shrinks Brain Volume by Removing Amyloid Plaques - Neuroscience News
Brain volume loss linked to new Alzheimer’s immunotherapies, such as lecanemab, is caused by the removal of amyloid plaques rather than neuronal damage.
By: Neurosciencenews.com
- Nov 27 2024
- 0
- 0 Views
Summary: Brain volume loss linked to new Alzheimers immunotherapies, such as lecanemab, is caused by the removal of amyloid plaques rather than neuronal damage. Researchers analyzed data from multipl… [+4018 chars]